Article
JX401, A p38alpha inhibitor containing a 4-benzylpiperidine motif, identified via a novel screening system in yeast.
Molecular pharmacology - 1 Oct 2006
Friedmann Yael, Shriki Anat, Bennett Estelle R, Golos Stella, Diskin Ron, Marbach Irit, Bengal Eyal, Engelberg David
Abstract excerpt
In vivo screening of compounds for potential pharmacological activity is more advantageous than in vitro screening. In vivo screens eliminate the isolation of compounds that cannot cross biological membranes, are cytotoxic, or are not specific to the target. However, animal-based or even cell-based systems are usually expensive, time-consuming, and laborious. Here we describe the identification of inhibitors of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
